NEW YORK — Tally Health has signed an agreement to sell its epigenetic age test and nutritional supplements through Cenegenics' treatment centers, the personal wellness companies said on Thursday.

纽约 — 塔利健康公司周四表示，已签署协议，将通过森尼吉克斯的治疗中心销售其表观遗传年龄测试和营养补充剂。

Included in the deal is Tally Health's cheek swab-based TallyAge test, which analyzes over 200,000 DNA methylation sites to generate data that the New York City-based company uses to provide customers with health and lifestyle recommendations.

交易中包含Tally Health基于颊拭子的TallyAge测试，该测试分析超过200,000个DNA甲基化位点，生成数据，纽约市的这家公司利用这些数据为客户提供健康和生活方式建议。

The companies said they will also collaborate to measure the effect of interventions using the TallyAge test. Financial and other terms were not disclosed.

这些公司表示，他们还将合作使用 TallyAge 测试来衡量干预措施的效果。财务条款及其他条款未披露。

Cenegenics, a subsidiary of Las Vegas-based BestLife Holdings, said it operates 21 centers throughout the US, as well as international locations in Greece, Colombia, Portugal, Mexico, Kenya, and Brazil.

Cenegenics是拉斯维加斯BestLife Holdings的子公司，该公司表示在美国运营21个中心，并在希腊、哥伦比亚、葡萄牙、墨西哥、肯尼亚和巴西设有国际分支机构。